Australia markets closed

Cellectis S.A. (CLLS)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
2.6500-0.0200 (-0.75%)
At close: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
No. of analysts8588
Avg. Estimate-0.22-0.31-1.27-1.12
Low estimate-0.68-0.46-1.91-1.87
High estimate0.27-0.24-0.51-0.37
Year ago EPS-0.59-0.58-2.33-1.27
Revenue estimateCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
No. of analysts7587
Avg. Estimate16.26M3.33M21.47M18.29M
Low estimate1.64M1.64M8.8M8.8M
High estimate45.39M7.5M52.64M40.6M
Year ago sales17.32M3.56M25.73M21.47M
Sales growth (year/est)-6.10%-6.40%-16.50%-14.80%
Earnings history30/12/202230/03/202329/06/202329/09/2023
Est. EPS-0.71-0.48-0.45-0.42
Actual EPS-0.59-0.58-0.19-0.31
Difference0.12-0.10.260.11
Surprise %16.90%-20.80%57.80%26.20%
EPS trendCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
Current estimate-0.22-0.31-1.27-1.12
7 days ago-0.22-0.31-1.27-1.12
30 days ago-0.22-0.31-1.27-1.12
60 days ago-0.29-0.32-1.27-1.12
90 days ago-0.29-0.32-1.27-1.12
EPS revisionsCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCLLSIndustrySector(s)S&P 500
Current qtr.62.70%N/AN/AN/A
Next qtr.46.60%N/AN/AN/A
Current year45.50%N/AN/AN/A
Next year11.80%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A